Skip to main content

4 Result(s)

within Article Remove this filter J Hansz Remove this filter Hematology Remove this filter

and

  1. No Access

    Article

    Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy

    Our previously published study showed promising results of autologous stem cell transplantation (ASCT) in patients with primary resistant Hodgkin's disease (HD). Probabilities of overall survival (OS) and prog...

    J Czyz, R Szydlo, W Knopinska-Posluszny, A Hellmann… in Bone Marrow Transplantation (2004)

  2. No Access

    Article

    Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning

    Allogeneic stem cell transplantation (SCT) using reduced-intensity conditioning (RIC) has potential to be a promising treatment of aggressive chronic lymphocytic leukemia (CLL). Since available clinical data o...

    P Dreger, R Brand, J Hansz, D Milligan, P Corradini, J Finke, G L Deliliers… in Leukemia (2003)

  3. No Access

    Article

    High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group

    We analysed the treatment outcome of primary refractory HD patients managed with high-dose chemotherapy and haematopoietic cell transplantation. Data of 65 adult patients who underwent HDC/ASCT in nine Polish ...

    J Czyż, A Hellmann, R Dziadziuszko, J Hansz, J Goździk… in Bone Marrow Transplantation (2002)

  4. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner… in Annals of Hematology (1992)

    Download PDF (18571 KB)